Genetic hemochromatosis and the HFE gene

Authors
Citation
R. Moirand, Genetic hemochromatosis and the HFE gene, B ACA N MED, 184(2), 2000, pp. 325-336
Citations number
42
Categorie Soggetti
General & Internal Medicine
Journal title
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE
ISSN journal
00014079 → ACNP
Volume
184
Issue
2
Year of publication
2000
Pages
325 - 336
Database
ISI
SICI code
0001-4079(2000)184:2<325:GHATHG>2.0.ZU;2-7
Abstract
The discovery of the HFE gene has lead to considerable improvement in the u nderstanding and the management of genetic hemochromatosis. More than 90 % of well-defined patients are homozygous for the C282 Y mutation, and geneti c testing has become an important diagnostic tool. The significance of the other mutations in the HFE gene remain controversial : only C282Y / H63D co mpound heterozygotes could present with a phenotype compatible with hemochr omatosis, but with a mild expression and a low penetrance. The link between iron overload and HFE mutation is explained by the interaction between HFE protein, beta-2-microglobulin and transferrin receptor; which is abolished by the C282Y mutation, but is not yet fully understood.